baber/WOPTO huggingface dataset:
Patent NZ-555849-A (NZ)
Title: Spa pool heater with an optical water sensor
Inventor: HUGHSON LESLIE THOMAS
Filed: 2007-06-12
Abstract: A water heater for a spa pool comprising a heating element (1) inside a heater body (2) with an optical water sensor (5) to detect the absence or presence of water in the heater body. The optical water sensor (5) comprises an LED light source, a transmitting medium for transmitting light from the light source and a light detector capable of detecting light. The light source and light detector are mounted in the same plane with an opaque barrier between them and encapsulated in the transmitting medium, which is cone-shaped. In the absence of water, light from the light source is reflected internally by the transmitting medium into the light detector. In the presence of water the light from the light source transmits through the transmitting medium and into the water and therefore does not reach the light detector.
Patent NZ-562468-A (NZ)
Title: Purine and imidazopyridine derivatives for immunosuppression
Inventor: OHLMEYER MICHAEL
IPC: A61K31/52
Filed: 2006-04-05
Abstract: Disclosed is a compound of formula I, wherein Q1 and Q2 are each CX1, CX2, or nitrogen, Q3is N or CH, V1 and V2 are each CH or N, R1is hydrogen or methyl y is from 0 to 3, each R2 and R3are hydrogen or (C1-C6)alkyl, and wherein the rest of the substituents are as defined in the specification. Also disclosed is the use of the compound to treat disorder which are dependent upon inhibition of Janus kinase 3, such as an autoimmune disease, an inflammatory disease, a mast cell mediated disease, cancer, haematological malignancy such as chronic myelogenous leukemia or anaplastic large cell lymphoma, organ transplant rejection such as in a kidney transplant, cardiovascular disease, colon cancer, pancreatic cancer, lymphoma, psoriasis, rheumatoid arthritis, or keratoconjunctivitis sicca.
Patent NZ-563859-A (NZ)
Title: Off flavor (flavour) controlling method in raw milk and pasteurized milk, and pasteurized milk processed using the method
Inventor: OHMORI TOSHIHIRO
IPC: A23C3/00
Filed: 2006-06-14
Abstract: Disclosed is a method of controlling off flavor in raw milk and pasteurized milk, comprising conducting a treatment of reducing dissolved oxygen concentration in a course between milking and pasteurization in processing of bovine milk. Also disclosed is pasteurized milk processed by the above method.
Patent NZ-567255-A (NZ)
Title: Coupling a conduit to a conductor inside the conduit so they have opposite current flow, giving zero potential at the conduit outer surface
Inventor: VINEGAR HARLOLD J
IPC: E21B36/00
Filed: 2006-10-20
Abstract: Disclosed is a method of heating a subsurface hydrocarbon containing formation. The method comprise the steps of: providing a system with a ferromagnetic conduit (218) and an electrical conductor (226) within the conduit; applying current to the system; and allowing the conduit to generate heat. The conductor is coupled to the conduit in series so that current flows in the conductor in an opposite direction to current flow in the conduit during the application of current to the system. The current is applied so the flow of electrons is confined to the inside of the conduit by the filed generated from flow in the conductor, making the outside surface of the conduit have zero potential at 25 degree C.
Patent NZ-574957-A (NZ)
Title: Capsule for the preparation of a beverage where the capsule has an overflow wall with an overflow aperture
Inventor: OZANNE MATTHIEU
IPC: A47J31/14
Filed: 2007-08-24
Abstract: Disclosed is a capsule for the preparation of a beverage in a beverage machine. The machine comprises an enclosure containing one or more beverage ingredients, filtering means (22) delimiting at least one filtering side of the enclosure, beverage flow guiding means (40) for guiding the beverage to a beverage outlet (41b) of the capsule, a shell and a protective cover (4) that is attached to the shell in order to form a gas tight container for the beverage ingredients. The capsule further comprises an overflow wall (3) that is positioned in the path of the brewed liquid after the filtering means and comprises at least one overflow aperture. The capsule further comprises opening means comprising an opening element (43) configured to open the gas-tight container in order to create the beverage outlet (41).The beverage flow guiding means and the opening element are integrally housed in the gas-tight container.
Patent NZ-577343-A (NZ)
Title: Process for the preparation of biphosphonic acids and salts thereof
Inventor: BAPTISTA JOANA
IPC: C07F9/38
Filed: 2007-11-06
Abstract: Disclosed is a process for producing a biphosphonic acid such as etidronic acid, zoledronic acid, risedronic acid, pamidronic acid, alendronic acid or ibandronic acid, which process comprises reacting a carboxylic acid compound or a salt thereof with phosphorous acid and phosphorous trichloride in an aprotic polar solvent selected from N,N'-dimethylethyleneurea (DMEU), N,N'-dilnethylpropyleneurea (DMPU), 1-methyl-2-pyrrolidone (NMP), or a mixture of two or more thereof.
Patent NZ-579319-A (NZ)
Title: Innerspring Mattress System
Inventor: GIANNOPOULOUS GEORGE
IPC: A47C23/00
Filed: 2009-08-28
Abstract: A mattress comprising a first border member configured to define an upper periphery of the mattress, a second border member 22 configured to define a lower periphery of the mattress, and at least two spring assemblies positionable within the first and second border members so as to extend between the first and second border members, wherein each spring assembly comprises an array of coil springs 14 and each spring assembly is positioned such that the coil springs 14 of one spring assembly are not directly connected with coil springs 14 of any other spring assembly.
Patent NZ-579650-A (NZ)
Title: A method of monitoring animals having RFID tags and RFID reader
Inventor: O'CONNELL BRENDAN
IPC: G06F17/40
Filed: 2010-09-15
Abstract: A method of monitoring an animal having an RFID tag attached thereof and an RFID reader are disclosed. The RFID reader (1) comprises an RFID receiver arranged to download information that is or can be associated with an electronic ID of an RFID tag to an RFID reader; memory for storing the downloaded information; a display (2) for displaying at least some of the downloaded information; and a processor (12) adapted to display at least some of the downloaded information stored in memory when the electronic ID of an RFID tag is read. For certain downloaded information: the processor is further arranged to receive a mandatory input to the RFID reader before a further RFID tag can be read, whereupon the mandatory input requiring a selection to be made and actioned on the RFID reader, the processor is further arranged to detect a selection made by actuating a first input device of the RFID reader and action that selection upon detecting the actuation of a second input device of the RFID reader.
Patent NZ-581162-A (NZ)
Title: Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
Inventor: CHEREZE NATHALIE
IPC: C07D403/14
Filed: 2008-05-14
Abstract: A pyrimidine derivative of formula (I) wherein X, Z, R1-R7, m and n are defined in claim 1. Also claimed is a process for the synthesis of the compound of formula (I) by reacting a compound of formula (II) with a compound of formula (III). The compound of formula (I) is a glycogen synthase kinase 3-beta (GSK3-beta) inhibitor and can be used to treat a neurodegenerative disease, cancer, malaria, bone diseases, Pemphigus vulgaris and neutropenia induced by cancer chemotherapy.
Patent NZ-585431-A (NZ)
Title: Polynucleotides and methods for improving plants
Inventor: PUTHIGAE SATHISH
IPC: A01H5/00
Filed: 2008-11-26
Abstract: Disclosed is a method for producing a plant with altered biomass, the method comprising transformation of a plant cell or plant with: a) a polynucleotide including a sequence encoding a polypeptide with the amino acid sequence of SEQ ID NO:1 or a variant of the polypeptide with at least 70% identity to the amino acid sequence of SEQ ID NO: 1 over its entire length; or b) a polynucleotide comprising a fragment, of at least 15 nucleotides in length, of the polynucleotide of a); or c) a polynucleotide comprising a compliment, of at least 15 nucleotides in length, of the polynucleotide of a); or d) a polynucleotide comprising a sequence, of at least 15 nucleotides in length, capable of hybridising to the polynucleotide of a) under stringent conditions. Further disclosed are isolated polynucleotides having at least 90% sequence identity to a nucleotide sequence that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 1, wherein the polynucleotide encodes a polypeptide capable of modulating biomass in a plant. Further disclosed are methods and isolated polypeptides as defined above according to SEQ ID NO: 10 as defined herein.
Patent NZ-586164-A (NZ)
Title: Method of degrading beta-glucan via hydrolysis in acidic solution
Inventor: KAUKOVIRTA-NORJA ANU
IPC: A23L7/10
Filed: 2008-12-18
Abstract: Disclosed is a method of degrading plant-based beta-glucan into a reduced molecular size in a controlled manner, characterized by subjecting the beta-glucan to hydrolysis in a flour like form or in the form of a doughy mass in a closed space under pressure in the presence of an acid solution at an elevated temperature followed by cooling, thus yielding a degraded beta-glucan product. Also disclosed is a degraded beta-glucan wherein the ratio of [1,4]beta-glucan to [1,3]beta-glucan is the same as that of native beta-glucan. The degraded beta-glucan can be separated from insoluble plant fibre and incorporated into foodstuffs such as beverages as a functional nutritional supplement.
Patent NZ-592364-A (NZ)
Title: Integrated swash plate pump and motor for compressible and elastic fluids such as explosive gases
Inventor: DALZIEL LINDSAY BRUCE
IPC: F04C21/00
Filed: 2009-09-18
Abstract: 592364 Disclosed is a swash pump for pumping a compressible fluid including explosive gases. The pump uses sealing contacts made between the nutatable swash plate and the fixed cone plates to centre and locate the inner swash sphere which slides against two resiliently mounted ring seals only, to reduce pump friction. A slanted end of a common drive shaft is supporting and turned by the rotor of an integrated, variable speed motor causes nutation of the sphere. All bearings, including axially slidable roller bearings inside the sphere, settle in position with respect to the common shaft to reduce frictional loss.
Patent NZ-597884-A (NZ)
Title: Phage ?29 dna polymerase chimera
Inventor: BLANCO DAVILA LUIS
IPC: C07K1/107
Filed: 2010-07-01
Abstract: 597884 Disclosed is a DNA polymerase chimera comprising: a) an amino acid sequence encoding a ?29 type DNA polymerase, bound by its C-terminal end to b) a connecting amino acid sequence bound by its C-terminal end to c) an amino acid sequence comprising at least one helixhairpin-helix (HhH) domain.
Patent NZ-598991-A (NZ)
Title: Method and devices for treating sleep apnea and snoring
Inventor: SANDERS IRA
IPC: A61F2/02
Filed: 2007-02-06
Abstract: 598991 Disclosed is a tissue retractor device to prevent or treat sleep apnoea and snoring. The tongue retractor (LTR) indirectly retracts the tongue base by its implant site in the frenulum area. Or the LTR is inserted into the base of tongue to stiffen lax surface mucosa or mechanically couple it to internal tongue structures. The LTR can be inserted in or around the pharyngoglossal fold. This site allows retraction and stiffening of tongue base tissue as well as the soft palate and lateral pharyngeal wall. The tissue retractor comprises a single elastomeric piece comprising shaft sized for insertion into a soft tissue located in a patient's oral cavity or pharynx; and a foldable retractor member integrally formed with a first end of the shaft. The retractor member is positioned at an acute angle relative to the shaft in an undeployed position and positioned at an angle that is substantially perpendicular to the shaft in a deployed position. An anchor member is connected at or near a second end of the shaft, such that the retractor member is positioned on an external surface of the soft tissue when a tension on the shaft causes the retractor member to rotate into the deployed position the retractor member, the shaft, and the anchor member interacts to exert a pressure that prevents deformation of at least a portion of the soft tissue to prevent obstruction of the patient's airway. Neither the retractor member nor the anchor member are configured to be tethered to bone.
Patent NZ-599518-A (NZ)
Title: Particulate structuration for improving the dissolution kinetics of food powders
Inventor: MARABI ALEJANDRO
IPC: A23L35/00
Filed: 2008-03-17
Abstract: Disclosed is the adaptation of the dissolution kinetics of powders, e.g., food powders to a particular purpose. One embodiment relates to a Composite Particle to be dissolved comprising at least two solid soluble sub-particles, at least one of which has a negative heat of dissolution and is amorphous and at least one other is crystalline.
Patent NZ-601758-A (NZ)
Title: Modulation of chemosensory receptors and ligands associated therewith
Inventor: TACHDJIAN CATHERINE
IPC: C07D513/04
Filed: 2008-06-03
Abstract: 601758 Disclosed are 1H-2,1,3-benzothiadiazine derivatives as represented by the general formulae (IIIb) and (IIIb1); wherein the substituents are as defined herein. Representative compounds include N5-isopropyl-1H-benzo[c][1,2,6]thiadiazine-4,5-diamine-2,2-dioxide, 5-cyclopropyl-1H-benzo[c][1,2,6]thiadiazin-4-amine-2,2-dioxide, 4-amino-5-(propyloxy)-1H-benzo[c][1,2,6]thiadiazine-2,2-dioxide, 4-amino-5-(cyclopentoxy)-1H-benzo[c][1,2,6]thiadiazine-2,2-dioxide, 4-amino-5-(tetrahydro-2H-pyran-4-yloxy)-1H-benzo[c][1,2,6]thiadiazine-2,2-dioxide and 4-amino-5-(((2R,3S,4R)-3,4-dihydroxy-5-methoxytetrahydrofuran-2-yl)methoxy)-1H-benzo[c][1,2,6]thiadiazine-2,2-dioxide. Further disclosed is an ingestible composition comprising a compound as defined above, or a tautomer, salt, solvate, and/or ester thereof, wherein the ingestible composition is selected from the group consisting of food or beverage product, non-edible product (nutritional products and dietary supplements, over the counter medications, oral care products, and cosmetics), a pharmaceutical composition, and combinations thereof.
Patent NZ-602140-A (NZ)
Title: Insulin biomarkers
Inventor: PEMBERTON CHRISTOPHER JOSEPH
IPC: G01N33/53
Filed: 2009-03-12
Abstract: Disclosed is an isolated insulin signal peptide (INS-SP) fragment antibody or antigen-binding agent which selectively binds INS-SP (1-9) (SEQ ID NO:16 as disclosed in the specification). Also disclosed is a method for predicting, diagnosing or monitoring a biological event or disorder in a subject wherein the event or disorder correlates with the release of insulin signal peptide (INS-SP) fragment into the circulation by use of an antibody or antigen-binding agent which selectively binds INS-SP.
Patent NZ-602684-A (NZ)
Title: Scooter attachable to a child buggy and with a displaceable rear wheel
Inventor: ANDREWS JAMES RICHARD
IPC: B62B7/00
Filed: 2011-07-15
Abstract: A scooter 1 including a body made up of a deck chassis 2 having a footrest surface, a handle bar assembly, at least one linking member on the scooter 1 that engages a linking mechanism used to releasably attach the scooter 1 to a child buggy thereby linking the scooter 1 to the child buggy, and at least one rear wheel 6 and at least one front wheel 5 each supported by the body and rotatable around an axis. The at least one rear wheel 6 is moveable from a first fixed horizontal position when the scooter 1 is not linked to the child buggy to a second moveable horizontal position when the scooter 1 is linked to the child buggy via the linking mechanism. In the first position, the scooter rear wheel 6 or wheels is moved closer to the deck chassis 2 vertically so as to place the footrest surface of the deck chassis 2 in a substantially horizontal alignment with respect to a ground surface when the scooter 1 is not linked to the child buggy.
Patent NZ-604818-A (NZ)
Title: Variants of activin iib receptor polypeptides and uses thereof
Inventor: TAM LEI-TING TONY
IPC: C07K14/72
Filed: 2009-11-24
Abstract: Disclosed is an isolated protein comprising a stabilised activin IIB receptor polypeptide, wherein said polypeptide is selected from the group consisting of: (a) a polypeptide consisting of an amino acid sequence set forth in the group consisting of SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 12 and SEQ ID NO: 14; (b) a polypeptide having at least 90 % sequence identity to (a), wherein the polypeptide has a W or a Y at a position corresponding to position 28 of an amino acid sequence set forth in SEQ ID NO: 2 and a T at a position corresponding to position 44 of the amino acid sequence set forth in SEQ ID NO:2, wherein the polypeptide is capable of binding myostatin, activin A, or GDF-11, and (c) a polypeptide having at least 95 % sequence identity to (a), wherein the polypeptide has a W or a Y at a position corresponding to position 28 of the amino acid sequence set forth in SEQ ID NO: 2 and a T at a position corresponding to position 44 of the amino acid sequence set forth in SEQ ID NO:2, wherein the polypeptide is capable of binding myostatin, activin A, or GDF-11;wherein the sequences are disclosed in the specification. Also disclosed is a method of producing the above mentioned stabilised activin IIB receptor (svActRIIB) protein and the use of the protein in the manufacture of a medicament for increasing lean muscle mass.
Patent NZ-610691-A (NZ)
Title: Amine-containing absorption medium, process and apparatus for absorption of acidic gases from gas mixtures
Inventor: SEILER MATTHIAS
IPC: B01D53/14
Filed: 2011-11-10
Abstract: 610691 Disclosed is a process for the absorption of an acid gas such as carbon dioxide from a gas mixture with an absorption medium, wherein the absorption medium comprises an amine of formula I for example 4-(3-dimethylaminopropylamino)-2,2,6,6-tetramethylpiperidine, and at least water as a solvent. Also disclosed is a combination absorption medium which further comprises an amine of formula III. A device comprising the combination absorption medium, an absorption unit, desorption unit and a circulating absorption medium, for the separation of acid gases from a gas mixture is also disclosed.
Patent NZ-613605-A (NZ)
Title: Improvements in animal handling systems
Inventor: FAGAN ROBIN CHRISTOPHER FELTRIM
IPC: A61D3/00
Filed: 2012-08-16
Abstract: Animal handling system including an animal clamp (9) and a race (1) including a holding device with a first wall (3) and a second wall (7) defining a passage for an animal, the first wall having a panel (4) that is pivotable about a vertical axis.
Patent NZ-614608-A (NZ)
Title: Perimeter seismic slip joint clip
Inventor: JOHN FRANCIS KEEN
IPC: E04B9/12
Filed: 2013-08-22
Abstract: 614608 Disclosed is a clip for retaining ceiling panels against earthquakes in a suspended ceiling grid. A one-piece sheet metal clip that forms a slip joint with the lower flange of a grid tee and is permanently fixed to a wall at the wall angle. The clip is characterized by an inverted transverse channel that receives a hem of the horizontal leg of a wall angle. The inverted channel improves the aesthetics of the slip joint, wall angle, and tee assembly by allowing a bottom visible face of the clip to be located at the plane of a lower visible face of the wall angle. A visible misalignment of these surfaces is minimised. The inverted channel also allows the inboard portion of the clip to self-align with the wall angle thereby reducing the concentration, dexterity and time necessary to properly and quickly install a clip at a selected location on the wall angle.
Patent NZ-618912-A (NZ)
Title: Trpv1 antagonists including dihydroxy substituent and uses thereof
Inventor: TAFESSE LAYKEA
IPC: C07D417/14
Filed: 2012-06-21
Abstract: Provided are N-(benzo[d]thiazol-2-yl)-4-{ 5-[1,2-dihydroxyethyl]-3-halo/trifluoromethylpyridin-2-yl} -piperazin-1-yl-carboxamide derivative compounds of the general formula (I), wherein the variables are as defined in the specification. An example of the compounds is (5)-4-{ 5-[(5)-1,2-Dihydroxyethyl]-3-fluoropyridin-2-y1)-N-(5-fluorobenzo[d]thiazol-2-y1)- 2-methylpiperazine-1-carboxamide. The compounds are antagonists of Transient Receptor Potential Vanilloid 1 (TRPV1). The compounds may be useful in the treatment of pain, osteoarthritis, urinary incontinence, ulcers, inflammatory bowel diseases (IBDs) and irritable bowel syndrome (IBS).
Patent NZ-620977-A (NZ)
Title: Pyrazole compound and use thereof for medical purposes
Inventor: MIURA TOMOYA
IPC: C07D405/14
Filed: 2012-08-30
Abstract: A pyrazole compound represented by general formula [Ib], wherein the each symbol is defined in the specification, having SGLTI inhibitory activity or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use. The compounds are useful in the treatment or prevention of a metabolic disorder, for example type II diabetes mellitus.
Patent NZ-621803-A (NZ)
Title: Compositions comprising sugar-cysteine products
Inventor: NAGASAWA HERBERT T
IPC: C12P13/12
Filed: 2012-07-27
Abstract: The disclosure relates to a composition comprising one or more sugar-cysteine products, and at least 10 of the group consisting of: vitamin B1, vitamin B2, vitamin B3, vitamin B6, folate, vitamin B12, biotin, pantothenic acid, magnesium, copper, chromium, D-riboise, acetyl-l-carnitine, panex ginseng, green tea extract, rhodiola rosea, quercetin, CoQ10, glutamine, glucosamine, quercetin, milk thistle seed, alpha lipoic acid, vitamin C, and cordyceps; or at least 8 of the group consisting of vitamin C, selenium, cordyceps, curcumin, 10 resveratrol, alpha-lipoic acid, grape seed extract, quercetin, milk thistle extract, broccoli seed extract, aloe extract, and piperine. The sugar-cysteine product may be RibCys, GlcCys, GlycCys, FruCys, GlcNH2Cys, or GlcNHAcCys, The disclosure also relates to a method of preparing said compositions and their use in increasing ATP and/or glutathione in a mammal.
Patent NZ-631537-A (NZ)
Title: Compositions and methods for modulating apolipoprotein c-iii expression
Inventor: SWAYZE ERIC E
IPC: A61K31/7125
Filed: 2014-05-01
Abstract: Disclosed is a compound comprising a modified oligonucleotide and a conjugate group, wherein the modified oligonucleotide consists of 20 contiguous nucleobases complementary to an equal length portion of nucleobases 3533 to 3552 of SEQ ID NO: 3 (as defined in the specification), wherein the nucleobase sequence of the modified oligonucleotide is at least 80% complementary to SEQ ID NO: 3.
Patent NZ-715820-A (NZ)
Title: An animal shelter having improved interior topography
Inventor: THOMAS GEORGE POW
IPC: F24F7/02
Filed: 2011-12-15
Abstract: Disclosed is an animal shelter and bedding for the shelter, particularly for cattle or bovine animals, or other farmed animals to provide improved ventilation and drainage of waste products. The shelter comprises an airflow control means configured to direct airflow under the canopy from ambient airflow outside the shelter, the airflow control means includes a louvre board that is proximate said canopy to define an airflow gap between said louvre board and said canopy, flooring comprising one or more region(s) of raised sloping or curved surface topography, having a substantially sloping profile configured to support an animal on said slope, and defining at least one ridge, and bedding laid upon or integral with the one or more regions(s) comprising at least three layers parallel to each other; an upper layer facing the canopy, an intermediate layer, and a bottom layer, wherein at least one of an upper layer and intermediate layer are permeable to liquid, and the bottom layer is impermeable to liquid, wherein the airflow control means facilitates airflow to be directed over the one or more region(s) to evaporate at least some liquid contained in the bedding in operation.